{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:16:11Z","timestamp":1792034171070,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s12325-023-02436-x","type":"journal-article","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T14:02:45Z","timestamp":1675519365000},"page":"1357-1365","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Aminoglycoside-Related Nephrotoxicity and Ototoxicity in Clinical Practice: A Review of Pathophysiological Mechanism and Treatment Options"],"prefix":"10.1007","volume":"40","author":[{"given":"Tyler A.","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasneem","family":"Hiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disha","family":"Chaudhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arielle N.","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary R.","family":"Palowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahab","family":"Ahmadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7961-3931","authenticated-orcid":false,"given":"Elyse M.","family":"Cornett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,4]]},"reference":[{"key":"2436_CR1","unstructured":"Van Hoey Pharm NMD. Aminoglycoside antibiotics, Salem Press Encyclopedia of Health. Salem Press; 2023. https:\/\/search-ebscohost-com.aucmed.idm.oclc.org\/login.aspx?. Accessed 1 Feb 2023."},{"key":"2436_CR2","unstructured":"Beauduy CE, Winston LG. Aminoglycosides & spectinomycin. In: BG Katzung, editor. Basic & clinical pharmacology, 14th ed. New York: McGraw-Hill Education; 2017. . http:\/\/accessmedicine.mhmedical.com\/content.aspx?aid=1148440182. Accessed 26 May 2022."},{"key":"2436_CR3","unstructured":"Block M, Blanchard DL. Aminoglycosides. Treasure Island (FL): StatPearls; 2022. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK541105\/. Accessed 7 Dec 2022."},{"issue":"16","key":"2436_CR4","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2146\/ajhp140564","volume":"72","author":"MS Stankowicz","year":"2015","unstructured":"Stankowicz MS, Ibrahim J, Brown DL. Once-daily aminoglycoside dosing: an update on current literature. Am J Health Syst Pharm. 2015;72(16):1357\u201364. https:\/\/doi.org\/10.2146\/ajhp140564.","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"2436_CR5","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1128\/AAC.39.3.650","volume":"39","author":"DP Nicolau","year":"1995","unstructured":"Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother. 1995;39(3):650\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2436_CR6","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/BF00542215","volume":"24","author":"LA Bauer","year":"1983","unstructured":"Bauer LA, Edwards WA, Dellinger EP, Simonowitz DA. Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients. Eur J Clin Pharmacol. 1983;24(5):643\u20137. https:\/\/doi.org\/10.1007\/BF00542215.","journal-title":"Eur J Clin Pharmacol"},{"key":"2436_CR7","doi-asserted-by":"publisher","first-page":"194389","DOI":"10.1155\/2013\/194389","volume":"2013","author":"AL Ross","year":"2013","unstructured":"Ross AL, Tharp JL, Hobbs GR, McKnight R, Cumpston A. Evaluation of extended interval dosing aminoglycosides in the morbidly obese population. Adv Pharmacol Sci. 2013;2013:194389. https:\/\/doi.org\/10.1155\/2013\/194389.","journal-title":"Adv Pharmacol Sci"},{"issue":"1","key":"2436_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4103\/indianjotol.indianjotol_29_22","volume":"28","author":"P Pavlidis","year":"2022","unstructured":"Pavlidis P, Gouveris H, Nikolaidis V, Schittek GA. Changes of serum levels of caspase-3 after trauma and ototoxic damage of the cochlea in rabbits: an in vivo study. Indian J Otol. 2022;28(1):52. https:\/\/doi.org\/10.4103\/indianjotol.indianjotol_29_22.","journal-title":"Indian J Otol"},{"issue":"1","key":"2436_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/2052-0492-2-31","volume":"2","author":"S Sunder","year":"2014","unstructured":"Sunder S, Jayaraman R, Mahapatra HS, et al. Estimation of renal function in the intensive care unit: the covert concepts brought to light. J Intensive Care. 2014;2(1):31. https:\/\/doi.org\/10.1186\/2052-0492-2-31.","journal-title":"J Intensive Care"},{"issue":"3","key":"2436_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/pharmaceutics9030036","volume":"9","author":"SH Mahmoud","year":"2017","unstructured":"Mahmoud SH, Shen C. Augmented renal clearance in critical illness: an important consideration in drug dosing. Pharmaceutics. 2017;9(3):36. https:\/\/doi.org\/10.3390\/pharmaceutics9030036.","journal-title":"Pharmaceutics"},{"issue":"6","key":"2436_CR11","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1177\/0310057X0903700611","volume":"37","author":"TE Jones","year":"2009","unstructured":"Jones TE, Peter JV, Field J. Aminoglycoside clearance is a good estimate of creatinine clearance in intensive care unit patients. Anaesth Intensive Care. 2009;37(6):944\u201352. https:\/\/doi.org\/10.1177\/0310057X0903700611.","journal-title":"Anaesth Intensive Care"},{"issue":"10","key":"2436_CR12","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1177\/106002809202601001","volume":"26","author":"BJ Zarowitz","year":"1992","unstructured":"Zarowitz BJ, Robert S, Peterson EL. Prediction of glomerular filtration rate using aminoglycoside clearance in critically ill medical patients. Ann Pharmacother. 1992;26(10):1205\u201310. https:\/\/doi.org\/10.1177\/106002809202601001.","journal-title":"Ann Pharmacother"},{"issue":"8","key":"2436_CR13","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1097\/00003246-199108000-00012","volume":"19","author":"KG Hickling","year":"1991","unstructured":"Hickling KG, Begg EJ, Perry RE, Atkinson HC, Sharman JR. Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside clearance as by creatinine clearance in critically ill patients. Crit Care Med. 1991;19(8):1041\u20137. https:\/\/doi.org\/10.1097\/00003246-199108000-00012.","journal-title":"Crit Care Med"},{"issue":"7\u20138","key":"2436_CR14","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1345\/aph.1Q708","volume":"46","author":"V Grootaert","year":"2012","unstructured":"Grootaert V, Willems L, Debaveye Y, Meyfroidt G, Spriet I. Augmented renal clearance in the critically ill: how to assess kidney function. Ann Pharmacother. 2012;46(7\u20138):952\u20139. https:\/\/doi.org\/10.1345\/aph.1Q708.","journal-title":"Ann Pharmacother"},{"issue":"5","key":"2436_CR15","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1016\/j.annfar.2014.04.005","volume":"33","author":"V Blasco","year":"2014","unstructured":"Blasco V, Antonini F, Zieleskiewicz L, et al. Comparative study of three methods of estimation of creatinine clearance in critically ill patients. Ann Fr Anesth Reanim. 2014;33(5):e85\u201388. https:\/\/doi.org\/10.1016\/j.annfar.2014.04.005.","journal-title":"Ann Fr Anesth Reanim"},{"issue":"4","key":"2436_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s40620-013-0036-x","volume":"27","author":"JP Baptista","year":"2014","unstructured":"Baptista JP, Neves M, Rodrigues L, Teixeira L, Pinho J, Pimentel J. Accuracy of the estimation of glomerular filtration rate within a population of critically ill patients. J Nephrol. 2014;27(4):403\u201310. https:\/\/doi.org\/10.1007\/s40620-013-0036-x.","journal-title":"J Nephrol"},{"issue":"9","key":"2436_CR17","doi-asserted-by":"publisher","first-page":"536","DOI":"10.5414\/cp201541","volume":"49","author":"S Hennessy","year":"2011","unstructured":"Hennessy S, et al. Prescriber adherence to pharmacokinetic monitoring service recommendations for aminoglycoside dosing and the risk of acute kidney injury. Int J Clin Pharmacol Ther. 2011;49(9):536\u201344. https:\/\/doi.org\/10.5414\/cp201541.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"5","key":"2436_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1365-2710.2008.00947.x","volume":"33","author":"N Fukuoka","year":"2008","unstructured":"Fukuoka N, Aibiki M. Recommended dose of arbekacin, an aminoglycoside against methicillin-resistant Staphylococcus aureus, does not achieve desired serum concentration in critically ill patients with lowered creatinine clearance. J Clin Pharm Ther. 2008;33(5):521\u20137. https:\/\/doi.org\/10.1111\/j.1365-2710.2008.00947.x.","journal-title":"J Clin Pharm Ther"},{"key":"2436_CR19","unstructured":"Mahoney JRN. Hearing loss. Magill\u2019s medical guide (online edition). 2022. https:\/\/search-ebscohost-com.aucmed.idm.oclc.org\/login.aspx?direct=true%26db=ers%26AN=86194165%26site=edslive%26scope=site. Accessed 1 Feb 2023."},{"issue":"3","key":"2436_CR20","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1152\/physrev.00038.2013","volume":"94","author":"R Fettiplace","year":"2014","unstructured":"Fettiplace R, Kim KX. The physiology of mechanoelectrical transduction channels in hearing. Physiol Rev. 2014;94(3):951\u201386. https:\/\/doi.org\/10.1152\/physrev.00038.2013.","journal-title":"Physiol Rev"},{"issue":"2","key":"2436_CR21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1172\/JCI77424","volume":"125","author":"ME Huth","year":"2015","unstructured":"Huth ME, Han K-H, Sotoudeh K, et al. Designer aminoglycosides prevent cochlear hair cell loss and hearing loss. J Clin Investig. 2015;125(2):583\u201392. https:\/\/doi.org\/10.1172\/JCI77424.","journal-title":"J Clin Investig"},{"key":"2436_CR22","doi-asserted-by":"publisher","first-page":"1782659","DOI":"10.1155\/2020\/1782659","volume":"2020","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Tang D, Zhao L, et al. Liproxstatin-1 protects hair cell-like HEI-OC1 cells and cochlear hair cells against neomycin ototoxicity. Oxid Med Cell Longev. 2020;2020:1782659. https:\/\/doi.org\/10.1155\/2020\/1782659.","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"2436_CR23","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1007\/s00204-021-03067-3","volume":"95","author":"L Jiang","year":"2021","unstructured":"Jiang L, Zheng Z, He Y. Progress in protecting vestibular hair cells. Arch Toxicol. 2021;95(8):2613\u201323. https:\/\/doi.org\/10.1007\/s00204-021-03067-3.","journal-title":"Arch Toxicol"},{"issue":"3","key":"2436_CR24","doi-asserted-by":"publisher","first-page":"e0151557","DOI":"10.1371\/journal.pone.0151557","volume":"11","author":"J Chang","year":"2016","unstructured":"Chang J, Choi J, Rah YC, et al. Sodium selenite acts as an otoprotectant against neomycin-induced hair cell damage in a zebrafish model. PLoS ONE. 2016;11(3):e0151557. https:\/\/doi.org\/10.1371\/journal.pone.0151557.","journal-title":"PLoS ONE"},{"issue":"11","key":"2436_CR25","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1086\/420742","volume":"38","author":"CA Peloquin","year":"2004","unstructured":"Peloquin CA, Berning SE, Nitta AT, Simone PM, Goble M, Huitt GA, Iseman MD, Cook JL, Curran-Everett D. Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases. Clin Infect Dis. 2004;38(11):1538\u201344. https:\/\/doi.org\/10.1086\/420742.","journal-title":"Clin Infect Dis."},{"issue":"11","key":"2436_CR26","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s00467-016-3533-z","volume":"32","author":"SJ McWilliam","year":"2017","unstructured":"McWilliam SJ, Antoine DJ, Smyth RL, Pirmohamed M. Aminoglycoside-induced nephrotoxicity in children. Pediatr Nephrol. 2017;32(11):2015\u201325. https:\/\/doi.org\/10.1007\/s00467-016-3533-z.","journal-title":"Pediatr Nephrol"},{"key":"2436_CR27","doi-asserted-by":"crossref","unstructured":"Chou CL, Chuang NC, Chiu HW, et al. Aminoglycosides use has a risk of acute kidney injury in patients without prior chronic kidney disease. Sci Rep. https:\/\/www.nature.com\/articles\/s41598-022-21074-x. Accessed 7 Dec 2022.","DOI":"10.1038\/s41598-022-21074-x"},{"issue":"Suppl 47","key":"2436_CR28","first-page":"24","volume":"100","author":"AR Watson","year":"2007","unstructured":"Watson AR. Aminoglycosides, toxicity and cystic fibrosis. J R Soc Med. 2007;100(Suppl 47):24\u20138.","journal-title":"J R Soc Med"},{"issue":"11","key":"2436_CR29","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/0006-2952(90)90078-Y","volume":"40","author":"G Laurent","year":"1990","unstructured":"Laurent G, Kishore BK, Tulkens PM. Aminoglycoside-induced renal phospholipidosis and nephrotoxicity. Biochem Pharmacol. 1990;40(11):2383\u201392. https:\/\/doi.org\/10.1016\/0006-2952(90)90078-Y.","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"2436_CR30","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1128\/AAC.43.5.1003","volume":"43","author":"M-P Mingeot-Leclercq","year":"1999","unstructured":"Mingeot-Leclercq M-P, Tulkens PM. Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother. 1999;43(5):1003\u201312. https:\/\/doi.org\/10.1128\/AAC.43.5.1003.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"2436_CR31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1046\/j.1469-0691.2000.00105.x","volume":"6","author":"G Beaucaire","year":"2000","unstructured":"Beaucaire G. Does once-daily dosing prevent nephrotoxicity in all aminoglycosides equally? Clin Microbiol Infect. 2000;6(7):355\u201360. https:\/\/doi.org\/10.1046\/j.1469-0691.2000.00105.x.","journal-title":"Clin Microbiol Infect"},{"issue":"e1","key":"2436_CR32","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1136\/ejhpharm-2021-002868","volume":"29","author":"K Sadeghi","year":"2022","unstructured":"Sadeghi K, Shahrami B, Hosseini Fani F, Hamishehkar H, Mojtahedzadeh M. Detection of subclinical nephrotoxicity induced by aminoglycosides in critically ill elderly patients using trough levels and urinary neutrophil gelatinase-associated lipocalin. Eur J Hosp Pharm. 2022;29(e1):e63\u20136. https:\/\/doi.org\/10.1136\/ejhpharm-2021-002868.","journal-title":"Eur J Hosp Pharm"},{"issue":"1","key":"2436_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-58790-1","volume":"10","author":"SJ McWilliam","year":"2020","unstructured":"McWilliam SJ, Rosala-Hallas A, Jones AP, et al. A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis. Sci Rep. 2020;10(1):1\u20139. https:\/\/doi.org\/10.1038\/s41598-020-58790-1.","journal-title":"Sci Rep"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02436-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02436-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02436-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T10:37:47Z","timestamp":1680518267000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02436-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2436"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02436-x","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,4]]},"assertion":[{"value":"31 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}